M. Santoro

558 total citations
13 papers, 434 citations indexed

About

M. Santoro is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, M. Santoro has authored 13 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Radiation and 3 papers in Surgery. Recurrent topics in M. Santoro's work include Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (7 papers) and Advanced Radiotherapy Techniques (7 papers). M. Santoro is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (7 papers) and Advanced Radiotherapy Techniques (7 papers). M. Santoro collaborates with scholars based in United States. M. Santoro's co-authors include Alan J. Katz, Richard Ashley, M.R. Witten, Éric Baudin, Robert F. Gagel, James R. Vasselli, Jessica Read, Samuel A. Wells, Bruce G. Robinson and James A. Fagin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

M. Santoro

13 papers receiving 425 citations

Peers

M. Santoro
Jeffrey Michalski United States
Amy Hayden Australia
Karel A. Hinnen Netherlands
John Dombrowski United States
Mack Roach United States
M.R. Witten United States
M. Santoro
Citations per year, relative to M. Santoro M. Santoro (= 1×) peers Kazuhito Toya

Countries citing papers authored by M. Santoro

Since Specialization
Citations

This map shows the geographic impact of M. Santoro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Santoro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Santoro more than expected).

Fields of papers citing papers by M. Santoro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Santoro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Santoro. The network helps show where M. Santoro may publish in the future.

Co-authorship network of co-authors of M. Santoro

This figure shows the co-authorship network connecting the top 25 collaborators of M. Santoro. A scholar is included among the top collaborators of M. Santoro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Santoro. M. Santoro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Katz, Alan J., et al.. (2013). Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years. Radiation Oncology. 8(1). 118–118. 152 indexed citations
4.
Katz, Alan J., et al.. (2011). Stereotactic Body Radiation Therapy for Low- and Low-Intermediate-Risk Prostate Cancer: Is there a Dose Effect?. SHILAP Revista de lepidopterología. 1. 49–49. 18 indexed citations
5.
Katz, Alan J., et al.. (2011). Stereotactic Body Radiation Therapy for Low, Intermediate, and High-risk Prostate Cancer: Disease Control and Quality of Life. International Journal of Radiation Oncology*Biology*Physics. 81(2). S100–S100. 14 indexed citations
6.
Katz, Alan J., et al.. (2010). Stereotactic body radiotherapy for organ-confined prostate cancer. BMC Urology. 10(1). 1–1. 124 indexed citations
7.
Katz, Alan J. & M. Santoro. (2010). Quality of Life and Efficacy for Stereotactic Body Radiotherapy for Treatment of Organ Confined Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 78(3). S58–S58. 3 indexed citations
8.
Wells, Samuel A., Bruce G. Robinson, Robert F. Gagel, et al.. (2010). Vandetanib (VAN) in locally advanced or metastatic medullary thyroid cancer (MTC): A randomized, double-blind phase III trial (ZETA).. Journal of Clinical Oncology. 28(15_suppl). 5503–5503. 48 indexed citations
9.
Katz, Alan J., et al.. (2010). Stereotactic Body Radiotherapy as Boost for Organ-confined Prostate Cancer. Technology in Cancer Research & Treatment. 9(6). 575–582. 47 indexed citations
10.
Scalcione, Luke R., et al.. (2009). Primary Testicular Lymphoma Involving the Spermatic Cord and Gonadal Vein. Clinical Nuclear Medicine. 34(4). 222–223. 18 indexed citations
11.
Katz, Alan J. & M. Santoro. (2009). Cyberknife Radiosurgery for Early Carcinoma of the Prostate: A Three Year Experience. International Journal of Radiation Oncology*Biology*Physics. 75(3). S312–S313. 5 indexed citations
12.
Witten, M.R., J.A. Haas, Martin Feuerman, et al.. (2008). Prostate-specific Antigen (PSA) Kinetics of the Early Response to CyberKnife Robotic Fractionated Radiosurgery of the Prostate: Correlated Regression Analysis of Combined Data from Three Institutions. International Journal of Radiation Oncology*Biology*Physics. 72(1). S340–S341. 1 indexed citations
13.
Bruni, Renato, et al.. (1989). [Laparosplenectomy in Hodgkin's disease].. PubMed. 8(3-4). 127–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026